Authors


Jennifer Seminerio, MD

Latest:

Take-Home Messages for the Management of Crohn’s Disease

Experts in gastroenterology share advice for the treatment of patients of Crohn’s disease.


Maia Kayal, MD

Latest:

Future Directions in the Management of Ulcerative Colitis

Drs. Maia Kayal and David P. Hudesman discuss their hopes and future directions in the treatment of patients with ulcerative colitis.


Steve R. Ommen, MD

Latest:

Patient Education of HCM

Expert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.



Hassieb Din, MD

Latest:

Does Aggressive or Moderate Fluid Resuscitation Better Treat Acute Pancreatitis?

A recent randomized controlled trial showed the limitations of either option, despite being a cornerstone of care.


Andrew Iwach, MD

Latest:

Managing Glaucoma During COVID-19: Patients Point the Way to Improved Care

A new survey assessed patients’ confidence in their disease management during the pandemic, specific disease management concerns, and experiences with telemedicine.




Rakesh Jain, MD, MPH, Texas Tech University School of Medicine

Latest:

Optimizing Care for ADHD During COVID-19

Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.


Andrew L. Concoff, MD, FACR, CAQSM

Latest:

Introducing the Concoff Method: The Interface Between Sports Medicine and Rheumatology

In today's issue of Rheumatology Network, we introduce The Concoff Method, a new column by Andrew Concoff, M.D., a rheumatologist who serves as executive vice president and chief value medical officer of United Rheumatology. Over the course of the next year, Dr. Concoff will publish columns that address sports medicine, value in rheumatology and managing a medical practice in the era of COVID-19. In this inaugural issue of the column, he covers the interface between sports medicine and rheumatology.


Miguel Regueiro, MD

Latest:

Take-Home Messages for the Management of Crohn’s Disease

Experts in gastroenterology share advice for the treatment of patients of Crohn’s disease.


Jeremy Adler, DMSc, PA-C, DFAAPA, Pacific Pain Medicine Consultants

Latest:

Final Thoughts on the Opioid Crisis and Normalizing Naloxone

The multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.


Paul Doghramji, MD, FAAFP

Latest:

Access and Treatment of Insomnia in Primary Care Clinics

An expert in sleep medicine highlights challenges in prescribing DORAs and importance of discussing insomnia with patients in the primary care setting.


Fernando J. Martinez, MD, MS

Latest:

Clinical Pearls for the Management of IPF

Steven D. Nathan, MD, FCCP, and Fernando J. Martinez, MD, MS, share clinical pearls and advice for the management of IPF.


Amy Brennan

Latest:

Patient-Specific Characteristics Driving AD Treatment Regimen

Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.


Matthew M. Heeney, MD

Latest:

Practice Pearls for the Management of SCD

A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.


Margaret Bobonich, DNP, FNP-C, DCNP, FAANP

Latest:

Care Collaboration in Atopic Dermatitis

Experts in dermatology discuss patient education and clinical pearls to assist colleagues in the management of atopic dermatitis.


Cindy Steinberg

Latest:

Assessing the Draft Revised CDC Clinical Practice Guideline for Prescribing Opioids 2022

The Director of Policy and Advocacy for the US Pain Foundation addresses the important changes made to the updated draft of the CDC Clinical Practical Guideline for Prescribing Opioids 2022.



Jose Scher, MD

Latest:

Concurrent Management of Inflammatory Bowel Disease and Psoriatic Arthritis

Dr David Hudesman, Dr Jordan Axelrad, and Dr Jose Scher discuss strategies for managing coexisting inflammatory bowel disease and psoriatic arthritis and highlight the importance of a multidisciplinary approach to providing comprehensive care.


Nina Cosdon

Latest:

FDA Approves Arexvy, the First RSV Vaccine for Older Adults

Older adults with comorbidities, including diabetes and chronic heart and lung disease, are at an increased risk of RSV hospitalization and death.


Isabella Ciccone, MPH

Latest:

Prioritizing Sleep Health From a Public Health Standpoint

The past year has provided great steps forward in sleep science, and coupled with the lingering difficulties in care and the COVID-19 pandemic’s effects, the field is coming to a head to make sleep health a public health priority.


Emily Sims, MD

Latest:

Challenges in Managing Type 1 Diabetes and Pressing Need for New Therapies

Drs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes


Dean Karalis, MD

Latest:

Treatment Decisions and its Relation to Patient Accessibility

Final thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.


Gregory Mattingly, MD

Latest:

Improving Awareness for Depressive Disorders

Andrew J Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, comment on the need to improve awareness around depressive disorders and break the stigma of mental health treatment.




Michael Marmura, MD

Latest:

Helping Your Patients Avoid the Migraine Trigger Trap

Forget what you think you know about red wine or chocolate ‘activating’ migraine. Many commonly accepted “triggers” aren’t triggers at all.



Jeffrey Bratberg, PharmD, FAPhA, University of Rhode Island College of Pharmacy

Latest:

Final Thoughts on the Opioid Crisis and Normalizing Naloxone

The multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.

© 2023 MJH Life Sciences

All rights reserved.